ArticleEBioMedicine2025
Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes.
Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights.Frontiers in immunology · 2026Pooled it
- Targeting the GPR183/EBI2‒oxysterol axis in tuberculosis: Immunometabolic regulation and prospects for host-directed therapy.Clinical and translational medicine · 2026Review
- Dysregulated m6A RNA methylation in tuberculosis: association with altered methyltransferase expression and immune responses.BMC infectious diseases · 2026Article
Corrections and comments
- Update of
Authors and funding
20 authors.
Funding
Abstract
backgroundTuberculosis (TB) remains a leading cause of morbidity and mortality worldwide. Individuals with type 2 diabetes (T2D) are at increased risk of developing active TB, tend to present with more severe disease and experience adverse treatment outcomes compared to individuals without T2D co-morbidity. However, the underlying mechanisms responsible for increased susceptibility of patients with T2D to TB remain poorly understood.
methodsWe performed bronchoscopies and collected bronchoalveolar lavage fluid (BAL) from TB contacts with and without T2D in South Africa and obtained paired human alveolar macrophages (HAMs) and monocyte-derived macrophages (MDMs) for transcriptomic, epigenetic and functional assays.
findingsFollowing ex vivo infection with Mycobacterium tuberculosis (Mtb), T2D-HAMs had increased Mtb growth (p = 0.034) and elevated TNF production (p = 0.033). BAL fluid from patients with T2D contained fewer neutrophils (p = 0.018), with neutrophil frequency inversely correlating with Mtb growth in HAMs. Both T2D-HAMs (p = 0.0206) and T2D-MDMs (p = 0.0465) expressed less CD32 compared to control cells, with patients with T2D having fewer M1-like MDMs (p = 0.0072). Mtb-induced gene expression in T2D-HAMs was delayed, but genes involved in negative regulation of neutrophil migration were upregulated (FDR = 0.035), consistent with the reduced neutrophil recruitment to the lung. Epigenetic profiling revealed hypermethylation in T2D-HAM DNA compared to control HAMs, except for hypomethylated TNF signalling genes, aligning with increased TNF production.
interpretationOur findings demonstrate that T2D alters early HAM responses to Mtb, characterised by delayed gene transcription, epigenetically driven cytokine dysregulation and impaired neutrophil recruitment-collectively facilitating enhanced Mtb growth. This study provides the first comprehensive investigation of the diabetic HAM phenotype in the context of recent TB exposure, offering mechanistic insights into the increased TB susceptibility observed in patients with T2D.
fundingResearch reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the South African Medical Research Council (SAMRC) under the US-South African Program for Collaborative Biomedical Research, the National Research Foundation of South Africa, the National Health and Medical Research Council of Australia and the Mater Foundation. The Translational Research Institute is supported by the Australian Government. RNA-seq data was generated in the Genome Sequencing Facility, which is supported by UT Health San Antonio, the NIH and a CPRIT Core Facility Award.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.